Is it necessary to take temozolomide for grade 1 glioma?

Whether temozolomide is needed for grade 1 glioma needs to be decided based on the patient’s specific situation and the doctor’s advice.

Grade 1 gliomas are generally considered to be low-grade malignant tumors and have relatively good therapeutic effects. For the treatment of first-grade gliomas, the preferred method is surgical removal of the tumor. If the tumor is clearly located, small in size and does not invade important functional areas, the tumor tissue can be directly removed through craniotomy to achieve radical cure. For patients with completely resected first-grade gliomas, further adjuvant treatment may not be required after surgery, and only regular follow-up visits are required to monitor changes in the condition.

In some cases, such as when the tumor cannot be completely removed or when minimal residual disease is present, adjuvant treatment, including radiotherapy and chemotherapy, may need to be considered. Temozolomide, as an oral chemotherapy drug, has high anti-tumor activity and can effectively treat glioma. It can pass through the blood-brain barrier and kill tumor cells in the central nervous system, thereby controlling the growth of tumors.

For patients with grade 1 glioma, chemotherapy with temozolomide may be recommended if there is minimal residual disease after surgery or if the physician assesses that chemotherapy is needed to reduce the risk of recurrence. The specific plan and course of chemotherapy will be formulated according to the patient's specific situation and the doctor's recommendations to ensure the treatment effect and patient safety.

It should be noted that although temozolomide has a good therapeutic effect on glioma, it may also cause some side effects, such as nausea, vomiting, loss of appetite, tinnitus, etc. Therefore, during the use of temozolomide, patients need to closely monitor their physical condition and seek medical advice promptly if they feel unwell.